← Back to TCRT

Alaunos Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 15/05/2025
$0$0$0$0$0$0$0$0
−$1−$1−$1.2−$1.1−$1.1−$1.1−$1.1−$1.7
−$0.41−$0.59−$0.55−$0.63−$0.67−$0.70−$0.71−$1.05
2.41.92.21.71.61.61.61.6

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.